Form 4: Celularity Director Ling Boosts Stake via RSU Vesting

Celularity Inc. Director Geoffrey Ling, M.D., acquired 67,416 shares of Class A Common Stock through RSU vesting, increasing his total beneficial ownership to 111,795 shares.

Summary

• Geoffrey Ling, M.D., a Director of Celularity Inc. (CELU), acquired 67,416 shares of Class A Common Stock.
• The acquisition occurred on December 19, 2025, and was a result of Restricted Stock Units (RSUs) vesting under the Celularity Inc. 2021 Equity Incentive Plan.
• Each RSU represents a right to receive one share of the Issuer's Class A common stock.
• The transaction price for these shares was $0.00, indicating a grant or vesting event rather than a purchase.
• Following this transaction, Dr. Ling beneficially owns a total of 111,795 shares of Class A Common Stock.
• The filing was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged transaction.

Sentiment

Score: 7

Explanation: The vesting of RSUs for a director is generally a positive event, indicating continued alignment of interests and a scheduled increase in insider ownership, which can be interpreted as a sign of confidence.

Positives

• A Director increasing their beneficial ownership, even through vesting, can signal confidence in the company's future prospects.
• The vesting of RSUs aligns management's interests with those of shareholders, as their compensation is tied to the company's equity performance.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's financial performance or strategic direction.

Industry Context

Insider transactions, such as RSU vesting, are common in the biotechnology and pharmaceutical industries, where equity compensation is a significant component of executive and director remuneration. These transactions are closely watched by investors as they can provide insights into management's perspective on the company's value and future.

Stakeholder Impact

• Shareholders: The increase in a director's beneficial ownership through RSU vesting can be viewed positively, as it further aligns the director's financial interests with those of the shareholders, potentially signaling confidence in the company's long-term value.

Key Dates

Keywords

Celularity Inc., CELU, Geoffrey Ling, Director, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Equity Incentive Plan, Beneficial Ownership